Please login to the form below

bosentan

This page shows the latest bosentan news and features for those working in and with pharma, biotech and healthcare.

J&J agrees $30bn deal to acquire Actelion

Meanwhile, J&J claims the company's marketed products including its trio of pulmonary artery hypertension (PAH) drugs, including Tracleer (bosentan) - now facing generic competition - as well as follow-up drugs

Latest news

Actelion reports late-stage trial failure as J&J talks continue

Tracleer (bosentan) which has lost patent protection in the US and Europe. .
J&J back in frame to buy Actelion after Sanofi talks break down

Actelion has been through a difficult patch after losing patent protection for pulmonary artery hypertension (PAH) blockbuster Tracleer (bosentan), but is on the up with strong growth for follow-up PAH
J&J abandons talks with Actelion as another suitor circles

After a challenging couple of years following the loss of patent protection for pulmonary artery hypertension (PAH) blockbuster Tracleer (bosentan), Actelion is now riding high on the back of strong growth
Resurgent Actelion catches J&J's eye

Actelion's top-selling product Tracleer (bosentan) has already lost patent protection in some markets and saw sales slide 15% in the first nine months of the year to CHF 790m (
Actelion gets EU go-ahead for Uptravi in PAH

Tracleer (bosentan).

More from news
Approximately 3 fully matching, plus 20 partially matching documents found.

Latest appointments

J&J's Jane Griffiths named global head of Actelion

At that point it will gain marketed products that include a trio of pulmonary artery hypertension (PAH) drugs - Tracleer (bosentan), Opsumit (macitentan) and Uptravi (selexipag).
New associate director at Packer Forbes

Prior to this role she was a brand lead at pharma company Actelion where she spent several years on the marketing of hypertension treatment Tracleer (bosentan), during which time she worked

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Associate Medical Writer / Entry Level Medical Writer - Medical ...: DOE

Scientific Director - Medical Communications Agency - New York: Excellent Remuneration Package

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Senior Medical Writer: Salary TBC

Senior Medical Writer – Leading Medical Communications Agency – ...: Highly Competitive Remuneration Package

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Graduate / Entry Level Opportunities – Medical Communications – ...: Highly Competitive Remuneration Package

Experienced / Senior Medical Writer - MedComms - Cardiff - Wales: Excellent Salary and Benefits on offer

Account Director, Medical Education: Salary TBC

Senior / Principal Medical Writer – Medical Education - UK &...: Excellent Salary and Benefits on offer

Account Director – Cheshire based Medical Communications Agency...: D.O.E

Scientific Director - Medical Education - Cheshire & London ...: Excellent Remuneration Package

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Five key trends in precision and personalised healthcare: Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications: Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word: ...